back to Investors & News

News Releases

Oct 02, 2020
Axcella Announces Upcoming Presentations at AASLD’s The Liver Meeting® 2020
Sep 30, 2020
New Publication Highlights Therapeutic Potential of Endogenous Metabolic Modulators (EMMs)
Sep 29, 2020
Axcella Announces Upcoming Investor Conference Presentation
Sep 08, 2020
Axcella to Present at Upcoming Investor Conferences
Aug 27, 2020
Axcella’s Late-Breaker Data from AXA1125-003 Clinical Study Presented at the EASL Digital International Liver Congress
Aug 20, 2020
Axcella Announces Upcoming Late-Breaker Presentation at The Digital International Liver Congress 2020
Aug 17, 2020
Results of Axcella’s AXA1665-001 Clinical Study Published in Clinical and Translational Gastroenterology
Aug 05, 2020
Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results
Aug 03, 2020
Axcella to Report Second Quarter 2020 Financial Results and Hold Conference Call on August 5, 2020
Jun 17, 2020
Axcella Announces Patent Issuances Covering AXA1665
Displaying 1 - 10 of 24